NCT02208934
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
- Locations
-
- CIM-Sant Pau - IIB Sant Pau, HSCSP Barcelona, Spain
- Palobiofarma S.L. (molecule owner) Mataró, Barcelona, Spain
Clinical trial condition
Explore clinical trials studying Huntington Disease. Study availability and eligibility vary by location and protocol.
NCT02208934
NCT01485952
NCT01521585
NCT01339130
NCT01357681
NCT00497159
NCT00029874
NCT01914965
NCT01411150
NCT00592995